CVS Group plc Posting of Annual Report and Notice of AGM (2711S)

TIDMCVSG

RNS Number : 2711S

CVS Group plc

03 November 2023

3 November 2023

CVS Group plc

("CVS" or the "Company")

Posting of Annual Report and Notice of Annual General Meeting

CVS, one of the UK's leading providers of integrated veterinary services, announces that its Annual General Meeting ("AGM") will be held at The Pennoyer Centre, Station Road, Pulham St Mary, IP21 4QT on 29 November 2023 at 11:00am.

The Annual Report and Accounts for the financial year ended 30 June 2023 (the "Annual Report"), the Notice of AGM and proxy form were sent on 3 November 2023 to those shareholders who have requested hard copies. Shareholders who have elected to receive shareholder information electronically have been notified that the Annual Report and Notice of AGM are available on the Company's website at: https://www.cvsukltd.co.uk/investor-centre , and the forms of proxy are available to shareholders on request by contacting company.secretary@cvsvets.com .

The AGM is being held as a physical meeting. However, the Company strongly encourages shareholders to submit a proxy vote in advance of the AGM and to appoint the Chair of the meeting as their proxy, rather than a named person who may not be able to attend the meeting if circumstances change. Full details of voting arrangements are contained in the Notice of AGM.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

About CVS Group plc ( www.cvsukltd.co.uk )

CVS Group is an AIM-listed provider of veterinary services in the UK, Australia, the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its four markets, including nine specialist referral hospitals and 39 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,800 personnel, including c.2,300 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAXLLLBXFLFFBX

(END) Dow Jones Newswires

November 03, 2023 03:05 ET (07:05 GMT)

CVS (AQSE:CVSG.GB)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024